Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Update of guidelines of the AFSOS, SFRO, SFH, SFNCM, SFCE, GFRP for the management of radio-induced nausea and vomiting].
Faivre JC, Demoor-Goldschmitt C, Beddok A, Schmitt A, Malgras A, Quilliot D, Fabre J, Perrot A, Jovenin N, Dupin C, Pointreau Y, Scotté F, Bensadoun RJ, Charzat V, Thariat J. Faivre JC, et al. Among authors: jovenin n. Bull Cancer. 2024 Nov;111(11):1065-1076. doi: 10.1016/j.bulcan.2024.08.015. Epub 2024 Oct 9. Bull Cancer. 2024. PMID: 39384523 Free article. French.
AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting.
Faivre JC, Tomaszewski F, Demoor-Goldschmitt C, Beddok A, Malgras A, Schmitt A, Fabre J, Perrot A, Jovenin N, Salleron J, Clavère P, Pointreau Y, Scotté F, Bensadoun RJ, Block V, Thariat J. Faivre JC, et al. Among authors: jovenin n. Crit Rev Oncol Hematol. 2022 Dec;180:103825. doi: 10.1016/j.critrevonc.2022.103825. Epub 2022 Oct 9. Crit Rev Oncol Hematol. 2022. PMID: 36223807 Review.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporté I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM; PHARE trial investigators. Pivot X, et al. Lancet. 2019 Jun 29;393(10191):2591-2598. doi: 10.1016/S0140-6736(19)30653-1. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178155 Clinical Trial.
[Antineoplastic drug induced nausea and vomiting: What is the clinical practice in 2018? An update of AFSOS clinical guidelines].
Jovenin N, Eche-Gass A, Chèze S, Launay-Vacher V, Mayeur D, Rey JB, Joly F, Krakowski I, Scotté F; Groupe de travail du référentiel Association francophone pour les soins oncologiques de support (AFSOS) sur les nausées-vomissements induits par les traitements anti-cancéreux. Jovenin N, et al. Bull Cancer. 2019 May;106(5):497-509. doi: 10.1016/j.bulcan.2019.02.002. Epub 2019 Mar 25. Bull Cancer. 2019. PMID: 30922554 Review. French.
[Opioid switch and change of route of administration in cancer patients treated by morphine].
Michenot N, Rostaing S, Baron L, Faure S, Jovenin N, Hubault P, Delorme T, Collin E, Filbet M, Chvetzoff G, Delorme C, Minello C, Magnet M, Ammar D, Krakowski I, Poulain P. Michenot N, et al. Among authors: jovenin n. Bull Cancer. 2018 Nov;105(11):1052-1073. doi: 10.1016/j.bulcan.2018.06.011. Epub 2018 Sep 29. Bull Cancer. 2018. PMID: 30274680 Review. French.
[Constipation and cancer: Current strategies].
Gervais C, Ducrotté P, Piche T, Di Palma M, Jovenin N, Scotté F. Gervais C, et al. Among authors: jovenin n. Bull Cancer. 2016 Sep;103(9):794-804. doi: 10.1016/j.bulcan.2016.05.010. Epub 2016 Jun 21. Bull Cancer. 2016. PMID: 27341746 Review. French.
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.
Lledo G, Huguet F, Chibaudel B, Di Fiore F, Mineur L, Galais MP, Artru P, Blondin V, Dupuis O, Abdiche MS, Jovenin N, Pozet A, Bonnetain F, Attia M, Dahan L, de Gramont A. Lledo G, et al. Among authors: jovenin n. Eur J Cancer. 2016 Mar;56:115-121. doi: 10.1016/j.ejca.2015.12.020. Epub 2016 Feb 2. Eur J Cancer. 2016. PMID: 26845174 Clinical Trial.
52 results